Cargando…
Evaluation of poly (lactic-co-glycolic acid) nanoparticles to improve the therapeutic efficacy of paclitaxel in breast cancer
[Image: see text] Introduction: Paclitaxel (PTX) is a cornerstone in the treatment of breast cancer, the most common type of cancer in women. However, this drug has serious limitations, including lack of tissue-specificity, poor water solubility, and the development of drug resistance. The transport...
Autores principales: | Cabeza, Laura, El-Hammadi, Mazen M., Ortiz, Raul, Cayero-Otero, Maria D., Jiménez-López, Julia, Perazzoli, Gloria, Martin-Banderas, Lucia, Baeyens, Jose M., Melguizo, Consolación, Prados, Jose |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Tabriz University of Medical Sciences (TUOMS Publishing Group)
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9809141/ https://www.ncbi.nlm.nih.gov/pubmed/36644541 http://dx.doi.org/10.34172/bi.2022.23433 |
Ejemplares similares
-
Temozolomide: An Updated Overview of Resistance Mechanisms, Nanotechnology Advances and Clinical Applications
por: Ortiz, Raúl, et al.
Publicado: (2021) -
Nanomedicine and Hyperthermia for the Treatment of Gastrointestinal Cancer: A Systematic Review
por: Gago, Lidia, et al.
Publicado: (2023) -
Tripalmitin nanoparticle formulations significantly enhance paclitaxel antitumor activity against breast and lung cancer cells in vitro
por: Leiva, María Carmen, et al.
Publicado: (2017) -
Temozolomide Resistance in Glioblastoma Cell Lines: Implication of MGMT, MMR, P-Glycoprotein and CD133 Expression
por: Perazzoli, Gloria, et al.
Publicado: (2015) -
The Antitumor Activity of Sodium Selenite Alone and in Combination with Gemcitabine in Pancreatic Cancer: An In Vitro and In Vivo Study
por: Doello, Kevin, et al.
Publicado: (2021)